These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8993793)

  • 21. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
    King IB; Kristal AR; Schaffer S; Thornquist M; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):988-92. PubMed ID: 15824175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
    Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.
    Wu AH; Whittemore AS; Kolonel LN; Stanczyk FZ; John EM; Gallagher RP; West DW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):533-8. PubMed ID: 11352865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
    Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS;
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I; Weiss NS; Barnett MJ; Goodman GE; Chen C
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):286-91. PubMed ID: 18268111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
    Cussenot O; Azzouzi AR; Nicolaiew N; Mangin P; Cormier L; Fournier G; Valeri A; Cancel-Tassin G
    Eur Urol; 2007 Oct; 52(4):1082-7. PubMed ID: 17448593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
    Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
    Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body size and prostate cancer: a population-based case-control study in China.
    Hsing AW; Deng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Benichou J; Xie T; Gao YT
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1335-41. PubMed ID: 11142419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
    Parekh DJ; Ankerst DP; Baillargeon J; Higgins B; Platz EA; Troyer D; Hernandez J; Leach RJ; Lokshin A; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1966-72. PubMed ID: 17932343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
    Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
    Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal growth hormone concentrations in blood and the risk for prostate cancer: a case-control study.
    Fuhrman B; Barba M; Schünemann HJ; Hurd T; Quattrin T; Cartagena R; Carruba G; Muti P
    Prostate; 2005 Jul; 64(2):109-15. PubMed ID: 15666390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.
    Moorman PG; Hulka BS; Hiatt RA; Krieger N; Newman B; Vogelman JH; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):483-8. PubMed ID: 9641492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.